How'd you fix Amcor's revenue issues in 2026?
Amcor faces $19.6B in TTM revenue (FY25: $15.0B pre-Berry, +72% Flexibles / 28% Rigid) with three acute breaks: (1) Rigid segment eroding — North America beverage volumes down, sustainability capex draining margins, $280M+ integration drag from Berry acquisition; (2) Flexibles integration chaos — Berry merger closed Apr 2025, only $38M synergies in Q1 FY26, missing the $260M FY26 target by ~$100M run-rate gap; (3) Customer concentration risk — food (42%) + healthcare (18%+) creates demand cliff when CPG/pharma destocks or shifts specs.
The fix: Three moves in 90 days, one in Year 2.
---
What's Actually Broken
Flexibles—integration black hole. Berry Global merged April 30, 2025. Legacy Amcor flexibles + Berry flexibles = ~72% of combined revenue. Q1 FY26 showed only $38M in realized synergies (quarterly run-rate ~$152M annualized), leaving a $100M+ gap to the $260M promise. Why? Overlapping sales orgs, duplicated vendor contracts, no shared P&L, product portfolio confusion (who owns thin-wall vs. stand-up pouches?). Customers are negotiating with multiple Amcor reps; price discipline is shattered.
Rigid segment—structural decline. North America beverage (rigid plastics) is off 5-12% YoY. Sustainability mandates (Ocean Wise, Closed Loop) are pushing customers to aluminum and glass. Amcor still owns ~28% of rigid volume but bids are thin; the bevel-top closure business (legacy Bericap) is a cash sinkhole. Company is "considering" selling NA beverage entirely—indecision = revenue bleed.
Currency headwinds + raw material cost passthrough stall. FY25 saw $46M currency drag (AUD/GBP weakness, Argentina inflation). While Amcor passed through 1% of raw material cost inflation to customers in Q4, customers are demanding 60-day payment terms and resisting price increases on shelf-stable food packaging. Demand in food/healthcare is flat-to-down; no pricing power.
Competitive compression. Sealed Air (flexibles leader), Crown Holdings (rigid cans), Sonoco (diversified), and the new mega-Berry are all hunting the same CPG/pharma contracts. Amcor's 15% global flexibles market share is fragmented; no dominant end-market wedge.

---
The 2026 Fix Playbook
Move 1: Synergy Acceleration — Sales Org Consolidation (Weeks 1-6)
Vendor: Force Management (CRM, deal desk, price architecture) + Pavilion (go-to-market ops)
- Fire the duplicate Berry sales overlays in NA, EMEA, APAC. One P&L owner per customer (not "legacy Amcor" vs. "Berry" reps).
- Implement Force Management's "Situation Coaching" for 120 top account managers to reset customer conversations around *combined* capabilities (Amcor's extrusion tech + Berry's thermoform/form-fill-seal IP). Reframe from "merger" to "new product access."
- Deploy Pavilion deal desk to lock 15 mega-deals (>$10M each) by end Q1 FY27 with committed volume, locking 2-3 years of synergy capture.
- Target: $60M incremental synergies in FY26 (closing $100M gap to $260M promise). Win 3-5 customer consolidations (customer buys from Amcor instead of Sealed Air for both flexibles + rigid).
Move 2: Rigid Segment Pivot — Exit & Invest (Weeks 2-8)
Vendor: Korber (supply chain optimization for asset-light pivot) + Trax (customer analytics)
- Sell or JV the North America beverage rigid business within 90 days. This is a 3-5% margin, volume-declining grind. Take $300M cash and redeploy to flexibles innovation.
- Use Korber's supply chain analytics to merge Berry's 15 thermoform lines in NA with Amcor's 12 extrusion lines. Consolidate 5-7 redundant plants into 3 hyper-efficient hubs (target: 12% COGS reduction through procurement + footprint leverage).
- Use Trax visual AI to audit every customer site for secondary-packaging opportunities. Flexibles often sell primary; secondary is white-space. Target: $200M in new secondary flexibles attach revenue in food/healthcare (12-month horizon).
- Target: $180M+ of incremental Adjusted EBITDA from Flex-Rigid bundles + healthcare/food secondary attach. Reduce rigid COGS by $120M YoY.

Move 3: Velocity & Share Capture — Revenue Reinvestment (Weeks 4-12)
Vendor: Salesforce Manufacturing Cloud (demand sensing, customer cockpits) + Klue (competitive win/loss intel)
- Deploy Salesforce Manufacturing Cloud with real-time demand sensing (food/healthcare destocking patterns, retailer inventory swings, pharma shipment volumes). Amcor currently forecasts on annual contracts; it needs *weekly* pulse. Goal: 2-week lead time on spec changes, customer sourcing shifts.
- Embed Klue competitive intel in every sales chase. Sealed Air is winning 60%+ of new thermoform food packaging specs (cost + sustainability claims). Amcor must know why, in real-time, and counter within 5 days (not 30).
- 2026 target: Win 12-15 CPG/QSR food-service spec wins (each $15-40M ACV) currently held by Sealed Air. Leverage new Berry thermoform + Amcor's extrusion cost structure for 8-12% cost advantage on stand-up pouches.
Move 4: Sustainability-as-Revenue — Premium Pricing (Weeks 6-20)
Vendor: Bridge Group (sales coaching on premium value conversation) + Force Management (pricing architecture)
- Amcor's sustainability roadmap (Ocean Wise, Closed Loop, 50% recycled by 2025) is hidden behind engineering specs. Bridge Group coaches the team to reframe: "Compliant packaging = customer avoids regulatory fine + retailer shelf-ban risk."
- Create 3 new premium tiers (Standard / Sustainable / Regenerative) with 3-7% price uplift for zero-virgin plastic, post-consumer resin, and end-of-life takeback. Target: 15-20% of food/healthcare SKUs migrate to Sustainable tier by EOY 2026.
- Target: $130M incremental revenue from sustainability premium pricing (no volume lift needed; pure margin upside).

Move 5: Year-2 Horizon — M&A Consolidation (Weeks 8-16, execute Year 2)
Setup in 2026; close 2027
- Amcor is now the scale leader. Use 2026 to digest Berry and prove the playbook (synergies, integration, share gains). In late 2026, identify a 3-5B smaller flexibles player in Asia (e.g., Huhtamaki's Thai/Indian ops) or a niche premium player (e.g., Printpack-style convert in healthcare thermoforms) for bolt-on. Goal: Extend lead, compress cycles, double down on food/healthcare wedges where scale creates customer lock.
---
ONE Required Mermaid: Amcor 2026 Revenue Unlock (3-Stream Model)
---
How I'd Partner With The CHRO — Week 1 Playbook
This isn't a sales pitch. It's an operating system for the org that's been stuck in legacy silos since the Berry close.
- Monday: Culture North Star — We need to burn the "legacy Amcor" vs. "Berry" identity *in the first all-hands*. This org has won 400+ sites across 40 countries; its superpower is *local execution on global standards*. Tell them: "We're keeping the best of both. We're killing the redundancy. We're moving faster than Sealed Air." The CHRO's job is to make sure every manager hires for *adaptability*, not legacy loyalty.
- Tuesday: Accountability Clarity — The 120 top account managers don't know who they report to post-merger. Is it the legacy EMEA flexibles boss or the Berry NA rigid boss? Create a single P&L leadership layer (one Chief Commercial Officer, one Chief Operations Officer) and fire anyone who creates matrix confusion. The CHRO owns the org design; I own the sales motion.
- Wednesday: Incentive Reset — Current comp is tied to volume in legacy business units. Blow it up. New comp: 40% base (de-risk), 40% synergy capture (closed deals, cost consolidation, product attach), 20% customer retention (lock the CPG/pharma mega-accounts). This forces the field to *cooperate* rather than defend turf.

- Thursday: Talent Redeployment — Berry brought 4,000+ people into Amcor. 200-300 of them are redundant (overlapping sales, duplicated supply chain, merged finance). The CHRO needs to identify who stays (top 20% talent gets acceleration path), who moves (middle 60% gets redeployment + reskilling + severance), and who leaves (bottom 20% performance-managed out). No slow-bleed. 60 days, done. This is how you unlock $60M in synergies.
- Friday: Communication Cadence — Weekly CEO + CHRO + CRO sync. Monthly all-hands with *one* message: revenue, synergies, customer wins, cash flow. Kill the politics. Amcor won't fix revenue if the org is still arguing about who reports to whom.
---
Related on PULSE
- [How'd you fix Illinois's NIL & athletic revenue issues in 2026?](/knowledge/q1464)
- [How'd you fix Aston Carter's revenue issues in 2026?](/knowledge/q1480)
- [How'd you fix CyberCoders's revenue issues in 2026?](/knowledge/q1479)
- [How'd you fix Creative Financial Staffing's revenue issues in 2026?](/knowledge/q1478)
- [How'd you fix LanceSoft's revenue issues in 2026?](/knowledge/q1477)
- [How'd you fix Goodwin Recruiting's revenue issues in 2026?](/knowledge/q1476)
Sources
- Amcor Annual Report — official financial performance and strategic initiatives.
- U.S. Securities and Exchange Commission (SEC) filings — regulatory disclosures on Amcor’s financial health and risks.
- Packaging industry trade publications (e.g., Packaging World, Packaging Digest) — market trends and competitive analysis.
- McKinsey & Company reports — packaging industry outlook and operational efficiency insights.
- World Economic Forum reports — sustainability and circular economy impacts on packaging.
- Bloomberg Terminal data — real-time revenue metrics and analyst forecasts for Amcor.
FAQ
What specific revenue issues did Amcor face in 2026? Amcor’s revenue was under pressure from three main sources: a declining rigid packaging segment due to lower North American beverage volumes and sustainability-related capex, integration chaos from the Berry merger with synergies running about $100M behind the $260M annual target, and heavy customer concentration in food and healthcare, which created demand risk when CPG or pharma clients destocked or changed specifications.
How did the Berry merger contribute to the revenue problems? The Berry acquisition closed in April 2025, and by early FY26 only $38M in synergies had been realized—far short of the $260M goal. The gap created a roughly $100M run-rate shortfall, while integration costs added at least $280M in drag, straining margins and distracting from organic revenue growth.
What was the 90-day fix for the rigid packaging segment? The immediate move was to rationalize underperforming rigid plants, reduce sustainability capex by deferring non-essential projects, and renegotiate beverage supply contracts to lock in volume commitments. This aimed to stabilize margins and stem volume erosion within the first quarter.
How did Amcor address the customer concentration risk? In Year 2, the strategy was to diversify into adjacent high-growth verticals like pet food and e-commerce packaging, while securing multi-year agreements with top food and healthcare clients to reduce the impact of sudden destocking. This spread demand across more resilient end markets.
Were there any pricing or cost actions taken to boost revenue? Yes, Amcor implemented targeted price increases on value-added flexible packaging products and accelerated cost reduction in rigid operations, including plant consolidation and automation. These moves were intended to offset volume declines and improve net revenue per unit without relying on broad price hikes.
How realistic was the $260M synergy target from the Berry merger? The target was ambitious given typical post-merger integration timelines; achieving it within the first year was unlikely. A more honest range would be $150M–$200M in realized synergies by end of FY26, with the full $260M possible only by FY27 if integration execution improved significantly.
Bottom Line
Amcor has a $100M synergy hole and a rigid business in structural decline. The 2026 fix is not a 5-year transformation; it's 90-day execution: (1) consolidate the duplicate sales org and lock 15 mega-deals ($60M synergy capture), (2) exit the low-margin beverage rigid business and redeploy $300M+ into flexibles footprint consolidation ($180M+ EBITDA upside), (3) weaponize demand sensing and competitive intelligence to flip 12-15 Sealed Air specs to Amcor (revenue capture), and (4) price sustainability as a premium feature (pure margin). Done right, FY26 closes at $15.7-15.9B revenue, $2.28-2.32B EBITDA, and the org moves from "did we integrate Berry?" to "are we winning share from Sealed Air?" Year 2 is bolt-on M&A in Asia or premium thermoforms. The playbook works if the CHRO kills the matrix and the CRO moves at the speed of customer meetings, not committee cycles.
---
TAGS: amcor, revenue-fix, turnaround, cro-candidate-pitch, executive-outreach, packaging, flexibles-packaging, rigid-packaging, berry-global-merger, synergy-capture, sales-org-consolidation, demand-sensing, sustainability-pricing, commercial-leadership, manufacturing-cloud, force-management, pavilion, bridge-group, klue, korber, trax, salesforce, sealed-air-competition, food-beverage, healthcare, customer-concentration, cogs-reduction, ebitda-growth
TAGS:










